3-(3',5'-Di-tert-butyl-4'-hydroxyphenyl)propionic acid
20170-32-5CC(C)(C)c1cc(CCC(=O)O)cc(C(C)(C)C)c1OWPMYUUITDBHVQZ-UHFFFAOYSA-Ndo not confuse with the phenothiazine phenosan
안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.
This chemical does not meet GHS hazard criteria for 75.9% (104 of 137) of all reports.
Warning
H302 (19%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 137 reports by companies from 5 notifications to the ECHA C&L Inventory.
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues.
Drugs used to cause dilation of the blood vessels.
용도It is employed as an active pharmaceutical intermediate.
20170-32-5DTXSID2066561